EDAP TMS S.A EBITDA Margin 2010-2024 | EDAP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for EDAP TMS S.A (EDAP) over the last 10 years. The current EBITDA margin for EDAP TMS S.A as of December 31, 2024 is .
| EDAP TMS S.A EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-12-31 |
$0.07B |
$-0.02B |
-31.88% |
| 2024-09-30 |
$0.07B |
$-0.02B |
-32.35% |
| 2024-06-30 |
$0.07B |
$-0.02B |
-32.84% |
| 2024-03-31 |
$0.07B |
$-0.02B |
-30.30% |
| 2023-12-31 |
$0.07B |
$-0.02B |
-33.33% |
| 2023-09-30 |
$0.06B |
$-0.02B |
-32.79% |
| 2023-06-30 |
$0.06B |
$-0.02B |
-26.67% |
| 2023-03-31 |
$0.06B |
$-0.01B |
-18.64% |
| 2022-12-31 |
$0.06B |
$0.00B |
-6.90% |
| 2022-09-30 |
$0.06B |
$0.00B |
-1.72% |
| 2022-06-30 |
$0.06B |
$0.00B |
-1.75% |
| 2022-03-31 |
$0.05B |
$0.00B |
-3.70% |
| 2021-12-31 |
$0.05B |
$0.00B |
-3.92% |
| 2021-09-30 |
$0.05B |
$0.00B |
-1.89% |
| 2021-06-30 |
$0.05B |
$0.00B |
1.89% |
| 2021-03-31 |
$0.05B |
$0.00B |
3.92% |
| 2020-12-31 |
$0.05B |
0 |
0.00% |
| 2020-09-30 |
$0.04B |
$0.00B |
-4.76% |
| 2020-06-30 |
$0.04B |
$0.00B |
-4.76% |
| 2020-03-31 |
$0.04B |
$0.00B |
-4.55% |
| 2019-12-31 |
$0.05B |
$0.00B |
1.96% |
| 2019-09-30 |
$0.05B |
0 |
0.00% |
| 2019-03-31 |
$0.05B |
$0.00B |
-2.17% |
| 2018-12-31 |
$0.05B |
$0.00B |
-2.22% |
| 2018-09-30 |
$0.04B |
$0.00B |
-4.76% |
| 2018-06-30 |
$0.04B |
$0.00B |
-4.88% |
| 2018-03-31 |
$0.04B |
$0.00B |
-2.44% |
| 2017-12-31 |
$0.04B |
$0.00B |
-2.56% |
| 2017-09-30 |
$0.04B |
$0.00B |
-2.56% |
| 2017-06-30 |
$0.04B |
0 |
0.00% |
| 2017-03-31 |
$0.04B |
0 |
0.00% |
| 2016-12-31 |
$0.04B |
$0.00B |
2.50% |
| 2016-09-30 |
$0.04B |
$0.00B |
9.76% |
| 2016-06-30 |
$0.04B |
$0.00B |
7.69% |
| 2016-03-31 |
$0.04B |
$0.00B |
7.69% |
| 2015-12-31 |
$0.04B |
$0.00B |
2.78% |
| 2015-09-30 |
$0.03B |
$0.00B |
-9.68% |
| 2015-06-30 |
$0.03B |
$0.00B |
-6.06% |
| 2015-03-31 |
$0.03B |
$0.00B |
-12.50% |
| 2014-12-31 |
$0.04B |
$0.00B |
-5.56% |
| 2014-09-30 |
$0.04B |
$0.00B |
-2.56% |
| 2014-06-30 |
$0.04B |
$0.00B |
-2.70% |
| 2014-03-31 |
$0.04B |
$0.00B |
-2.86% |
| 2013-12-31 |
$0.03B |
$0.00B |
-12.50% |
| 2013-09-30 |
$0.03B |
$0.00B |
-9.09% |
| 2013-06-30 |
$0.03B |
$0.00B |
-9.09% |
| 2013-03-31 |
$0.04B |
$0.00B |
-5.71% |
| 2012-12-31 |
$0.03B |
$0.00B |
-2.94% |
| 2012-09-30 |
$0.03B |
$0.00B |
-9.38% |
| 2012-06-30 |
$0.03B |
$0.00B |
-8.82% |
| 2012-03-31 |
$0.03B |
$0.00B |
-12.50% |
| 2011-12-31 |
$0.03B |
$0.00B |
-12.50% |
| 2011-09-30 |
$0.03B |
$0.00B |
-12.12% |
| 2011-06-30 |
$0.03B |
$-0.01B |
-16.13% |
| 2011-03-31 |
$0.03B |
$-0.01B |
-15.15% |
| 2010-12-31 |
$0.03B |
$-0.01B |
-18.75% |
| 2010-09-30 |
$0.03B |
$-0.01B |
-15.15% |
| 2010-06-30 |
$0.03B |
$-0.01B |
-18.18% |
| 2010-03-31 |
$0.03B |
$-0.01B |
-14.71% |
| 2009-12-31 |
$0.04B |
$-0.01B |
-14.29% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.082B |
$0.069B |
|
EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors.
|
